CRISPR THERAPEUTICS AG (CRSP) Operating margin 2016–2025
CRISPR THERAPEUTICS AG (CRSP) operating margin by fiscal year — reported operating income divided by reported revenue.
-18933.6%FY2025 · since FY2016: -1319.3% → -18933.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -18933.6% | -17683.3 pp |
| FY2024 | -1250.4% | -1190.4 pp |
| FY2023 | -60.0% | +56130.5 pp |
| FY2022 | -56190.4% | -56231.2 pp |
| FY2021 | 40.8% | +49336.4 pp |
| FY2020 | -49295.5% | -49311.7 pp |
| FY2019 | 16.1% | +5103.9 pp |
| FY2018 | -5087.8% | -4930.1 pp |
| FY2017 | -157.7% | +1161.6 pp |
| FY2016 | -1319.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice